Founded
Address
BioVentures Investors LLC
101 Main Street
Suite 1750
Cambridge, MA 02142
United States
Phone
Email
Recent investment activity
KANDO id: 21471
Corporate information
Registration country
Funds managed
| Fund | Type | Vintage | Currency | Committed capital |
|---|---|---|---|---|
| BioVentures Investors IV LP | Venture |
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 22 of 22| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Cardiosolutions Inc | Cardiosolutions, Inc. is a development stage company focused on a novel percutaneous alternative to open heart surgery . | N/A | |||
|
|
Enanta Pharmaceuticals Inc | Enanta Pharmaceuticals is a research and development company. | N/A | |||
|
|
HealthCare IT Inc | N/A | ||||
|
|
Hydra Biosciences Inc | N/A | ||||
|
|
HydroCision Inc | HydroCision is the leading developer, manufacturer, and marketer of fluidjet based surgical tools for the spine market. | N/A | |||
|
|
New Chemical Entities | With the advent of genomics, NCE developed targeted libraries of potential pharmaceutical compounds, geared toward protein interactions. | N/A | |||
|
|
Phase Forward Inc | N/A | ||||
|
|
Rcadia Medical Imaging Ltd. | Develops and markets proprietary systems for computerized analysis of medical images. | N/A | |||
|
|
Spirus Medical LLC | N/A | ||||
|
|
Vernalis | Pharmaceutical company | N/A | |||
|
|
Zalicus Inc | Combination drug development | N/A | |||
|
|
Biolex Therapeutics Inc | Series D | ||||
|
|
Claros Diagnostics Inc | point-of-care medical diagnostic company | Series B | |||
|
|
Claros Diagnostics Inc | point-of-care medical diagnostic company | Series A | |||
|
|
Cylene Pharmaceuticals Inc | Clinical stage private company developing small molecule drugs against newly validated cancer targets. | Series D | |||
|
|
Cylene Pharmaceuticals Inc | Clinical stage private company developing small molecule drugs against newly validated cancer targets. | Series C | |||
|
|
Cylene Pharmaceuticals Inc | Clinical stage private company developing small molecule drugs against newly validated cancer targets. | Series B | |||
|
Medtronic Inc | Medical technology company specializing in implantable and invasive therapies. | N/A | |||
|
|
Momelan Technologies Inc | MoMelan is developing a proprietary device platform for mechanically expanding autologous epidermal tissue for use in dermatologic conditions. | N/A | |||
|
|
Sciona Inc | Provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. | Series C | |||
|
|
Verax Biomedical Inc | Verax Biomedical is a privately held, venture backed medical products company. | Series E | |||
|
|
Verax Biomedical Inc | Verax Biomedical is a privately held, venture backed medical products company. | Series B |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Marc Goldberg | [email protected] | |||
| Anthony Coia | ||||
| Peter Feinstein | ||||
| Walter Gilbert |